Recent exceptional positive changes in investment behavior have benefitted OptimizeRX Corp (NASDAQ: OPRX): its shorter term price trend turned up, and positive upside/downside volume developed.
OptimizeRX Corp (NASDAQ: OPRX) has benefited from significant positive changes in fundamentals: the consensus estimate for December, 2024 increased significantly, and the consensus estimate for December, 2023 increased significantly.
In light of these very positive signals we are reviewing our current Overall Rating of F. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
OPRX is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
OptimizeRX has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. OptimizeRX has a poor Power Rating of 28 and a poor Appreciation Score of 20, and the Lowest Value Trend Rating results.
Recent Price Action
On 11/7/23, OptimizeRX Corp (NASDAQ: OPRX) stock declined by -1.2%, closing at $9.67. The stock has risen 24.1% during the last week but has been extremely weak relative to the market over the last nine months.
Be the first to comment